FINWIRES · TerminalLIVE
FINWIRES

Optimi Health Closes US$15.0 Million Public Offering of Shares

By

Optimi Health (OPTI.CN, OPTH), down 12.8% on last look, on Thursday said it raised US$15.0 million in the public share offering connected with its listing on the Nasdaq exchange.

Optimi Health, which operates in the field of psychedelic medicine, issued 2.4 million-shares at US$6.25 each. The shares began trading on Nasdaq on May 20, under the symbol "OPTH."

"This marks a significant milestone for Optimi," said chief executive Dane Steven. "This financing provides significant strength to our balance sheet and represents the necessary working capital for the growth of our business, with ample runway to scale over the next few years."

Optimi Health shares were last seen down $1.05, to $7.15, on the Toronto Stock Exchange.

Price: $6.95, Change: $-1.25, Percent Change: -15.24%

Related Articles

Mining & Metals

Whitecap Resources Receives TSX Approval For Renewed Normal Course Issuer Bid

Whitecap Resources (WCP.TO) said Thursday it received exchange approval to buy back and cancel up to 120.7-million shares as it renewed its normal course issuer bid for another 12 months.The company said the allowed amount represents 10% of its public float as of May 11. The renewed NCIB runs for a 12-month period beginning May 25.Whitecap said it had 1.22-billion common shares outstanding and 1.21-billion shares in its public float as of May 11.The company said purchases under the program will be subject to a daily limit of 1.53-million shares, representing 25% of the average daily trading volume of 6.11-million shares on the TSX for the six-month period ended April 30, 2026.Whitecap said it repurchased 18.9 million of an allowed 122.14-million shares in its expiring NCIB.Shares of the company closed down $0.33 at $16.85 on Toronto Stock Exchange on Wednesday.

$WCP.TO
Mining & Metals

Nanalysis Scientific Posts Narrower Loss, Higher Revenue for First Quarter

Nanalysis Scientific (NSCI.V) after trade Wednesday reported a narrower loss and higher revenue for the first quarter.The manufacturer of portable Nuclear Magnetic Resonance (NMR) spectrometers lost $1.28 million in the quarter, compared with a loss of $1.31 million a year earlier. The company said the decline in net loss was due to improved business margins in 2026.Total sales and revenue rose slightly to $10.7 million from $10.6 million in the year-ago quarter. "While there was a decline in product revenue due to lower NMR benchtop sales and the termination of the third-party equipment sales contracts, security services revenue increased primarily due to higher levels of project-related work associated with the Airport Security Maintenance Business," the company said.Adjusted EBITDA increased 62% to $292,000 from $180,000 in the first quarter of 2025. The company said this was mainly due to an increase in services margin and lower spending in sales and marketing expenses and general and administrative expenses, offset by lower product sales."Our outlook has not changed, and we continue to expect improved operational performance through 2026," Chief Executive Sean Krakiwsky said, adding that "while macroeconomic conditions continue to impact purchasing timelines in the Scientific Equipment segment, we remain focused on disciplined execution and long-term value creation across both operating segments."The company's shares closed unchanged at C$0.15 on the TSX Venture Exchange.

$NSCI.V
Mining & Metals

TriStar Gold Seeking C$7 Million From a Best-Efforts Private Placement of Share Units

Tristar Gold (TSG.V) on Thursday said it will raise up to $7 million in with a "best-efforts" private placement of share units.The company will place up to 30.44-million units at a price of C$0.23 each and made of a share and one half of a two-year warrant to buy a share for $0.30.Proceeds from the offering, which is scheduled to close on or about June 4, are expected to be used for exploration and development of the company's mineral properties, as well as for general working capital.Shares of the company closed up $0.02 at $0.27 on TSX Venture Exchange.

$TSG.V